| Financial Year |
September 30 2022 |
| Monetary Funds |
181,636,889.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
435,972,225.16 |
| Advances to Suppliers |
70,983,288.35 |
| Other Receivables |
31,167,800.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
501,321,574.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,515,653.02 |
| Total Current Assets |
1,274,922,299.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
311,460,732.78 |
| Under-construction Projects |
767,792.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
60,041,054.47 |
| Intangible Assets |
175,010,974.30 |
| R&D expenses |
66,743,567.95 |
| Goodwill |
67,421,341.85 |
| Long-Term Deferred and Prepaid Expenses |
11,017,155.66 |
| Deferred Income Tax Assets |
41,271,636.60 |
| Other Non-Current Assets |
40,672,924.86 |
| Sub-Total of Non-Current Assets |
779,581,004.36 |
| Total Assets |
2,054,503,303.75 |
| Short-Term Loans |
452,867,746.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,086,815.30 |
| Accounts Payable |
167,929,368.56 |
| Accounts Received In Advance |
11,194,603.51 |
| Employee Compensation Payable |
12,362,262.79 |
| Taxes Payable |
17,988,947.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,358,728.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
134,468,264.78 |
| Other Current Liabilities |
35,234,831.19 |
| Sub-Total of Current Liabilities |
912,835,617.00 |
| Long-term Loans |
37,405,957.64 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
57,287,500.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,936,129.74 |
| Deferred Income Tax Liabilities |
12,203,215.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
152,267,173.64 |
| Total Liabilities |
1,065,102,790.64 |
| Paid-In Capital(Or Share Stock) |
384,765,738.00 |
| Capital Surplus |
1,219,578,005.24 |
| Surplus Reserve |
32,322,298.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-675,933,071.24 |
| Minority Stockholder's Interest |
5,033,220.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
984,367,293.02 |
| Owner's Equity（Stockholder's Equity） |
989,400,513.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,054,503,303.75 |
